Bluejay Diagnostics (BJDX) Operating Expenses (2020 - 2026)

Bluejay Diagnostics (BJDX) has 7 years of Operating Expenses data on file, last reported at $1.9 million in Q1 2026.

• For the quarter ending Q1 2026, Operating Expenses rose 2.64% year-over-year to $1.9 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (up 5.62% YoY), and the FY2025 full-year result was $7.0 million, down 3.02% from the prior year.
• Operating Expenses improved to $1.9 million in Q1 2026, from $1.5 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $2.9 million in Q2 2023 to a low of $1.4 million in Q3 2024.
• A 5-year average of $2.1 million and a median of $2.0 million in 2022 frame the typical range for Operating Expenses.
• Across the five-year window, Operating Expenses jumped 786.91% in 2022 and sank 41.84% in 2024, its largest moves.
• Tracing BJDX's Operating Expenses over 5 years: stood at $2.5 million in 2022, then fell by 2.73% to $2.4 million in 2023, then tumbled by 37.8% to $1.5 million in 2024, then fell by 1.54% to $1.5 million in 2025, then surged by 32.64% to $1.9 million in 2026.
• Business Quant data shows BJDX's Operating Expenses at $1.9 million in Q1 2026, $1.5 million in Q4 2025, and $1.6 million in Q3 2025.